Literature DB >> 9150464

Can Alport syndrome be treated by gene therapy?

K Tryggvason1, P Heikkilä, E Pettersson, A Tibell, P Thorner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9150464     DOI： 10.1038/ki.1997.205

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  5 in total

1.  Identification of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen: implications for Alport gene therapy.

Authors:  Jeong Suk Kang; Selene Colon; Thomas Hellmark; Yoshikazu Sado; Billy G Hudson; Dorin-Bogdan Borza
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

2.  Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.

Authors:  L Heidet; Y Cai; L Guicharnaud; C Antignac; M C Gubler
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 3.  Familial hematurias: what we know and what we don't.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

4.  Transfer of the alpha 5(IV) collagen chain gene to smooth muscle restores in vivo expression of the alpha 6(IV) collagen chain in a canine model of Alport syndrome.

Authors:  Scott J Harvey; Keqin Zheng; Barbara Jefferson; Peter Moak; Yoshikazu Sado; Ichiro Naito; Yoshifumi Ninomiya; Robert Jacobs; Paul S Thorner
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 5.  Molecular and Cellular Mechanisms Underlying the Initiation and Progression of Alport Glomerular Pathology.

Authors:  Dominic Cosgrove; Jacob Madison
Journal:  Front Med (Lausanne)       Date:  2022-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.